Lung Injury Clinical Trial
Official title:
Effects of Different Ventilation Modes on Intraoperative Lung Injury and Postoperative Pulmonary Complications in Elderly Patients Undergoing Laparoscopic Colorectal Cancer Resection
In 1967, the term "respirator lung" was coined to describe the diffuse alveolar infiltrates
and hyaline membranes that were found on postmortem examination of patients who had undergone
mechanical ventilation.This mechanical ventilation can aggravate damaged lungs and damage
normal lungs. In recent years, Various ventilation strategies have been used to minimize lung
injury, including low tide volume, higher PEEPs, recruitment maneuvers and high-frequency
oscillatory ventilation. which have been proved to reduce the occurrence of lung injury.
In 2012,Needham et al. proposed a kind of lung protective mechanical ventilation, and their
study showed that limited volume and pressure ventilation could significantly improve the
2-year survival rate of patients with acute lung injury.Volume controlled ventilation is the
most commonly used method in clinical surgery at present.Volume controlled ventilation(VCV)
is a time-cycled, volume targeted ventilation mode, ensures adequate gas exchange.
Nevertheless, during VCV, airway pressure is not controlled.Pressure controlled
ventilation(PCV) can ensure airway pressure,however minute ventilation is not
guaranteed.Pressure controlled ventilation-volume guarantee(PCV-VG) is an innovative mode of
ventilation utilizes a decelerating flow and constant pressure. Ventilator parameters are
automatically changed with each patient breath to offer the target VT without increasing
airway pressures. So PCV-VG has the advantages of both VCV and PCV to preserve the target
minute ventilation whilst producing a low incidence of barotrauma pressure-targeted
ventilation.
Current studies on PCV-VG mainly focus on thoracic surgery, bariatric surgery and urological
surgery, and the research indicators mainly focus on changes in airway pressure and
intraoperative oxygenation index.The age of patients undergoing laparoscopic colorectal
cancer resection is generally higher, the cardiopulmonary reserve function is decreased, and
the influence of intraoperative pneumoperitoneum pressure and low head position increases the
incidence of intraoperative and postoperative pulmonary complications.Whether PCV-VG can
reduce the incidence of intraoperative lung injury and postoperative pulmonary complications
in elderly patients undergoing laparoscopic colorectal cancer resection, and thereby improve
postoperative recovery of these patients is still unclear.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2021 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: 1. scheduled for Laparoscopic colorectal cancer resection 2. age >65 years 3. body mass index(BMI) 18-30kg / m2 4. ASA grading?-? Exclusion Criteria: 1. history of lung surgery 2. severe restrictive or obstructive pulmonary disease (preoperative lung function test: forced vital capacity(FVC)< 50% predictive value of FVC,forced expiratory volume at one second(FEV1)< 50% predictive value of FEV1 3. Acute respiratory failure, pulmonary infection, ALI/ARDS, and acute stage of asthmaAcute respiratory failure, pulmonary infection, acute lung injury(ALI),acute respiratory distress syndrome(ARDS), and acute stage of asthma (bronchodilators were needed for treatment) were found within 1 month before surgery 4. Patients at risk of preoperative reflux aspiration 5. Preoperative positive pressure ventilation (as obstructive sleep apnea hypopnea syndrome patients) or long-term home oxygen therapy were performed 6. Serious heart, liver and kidney diseases: heart function class more than 3, severe arrhythmia (sinus bradycardia (ventricular rate < 60 times/min), atrial fibrillation, atrial flutter, atrioventricular block, frequent premature ventricular and polyphyly ventricular early, early to R on T, ventricular fibrillation and ventricular flutter), acute coronary syndrome, liver failure, kidney failure 7. Neuromuscular diseases affect respiratory function, such as Parkinson's disease, myasthenia gravis and cerebral infarction affect normal breathing 8. Mental illness, speech impairment, hearing impairment 9. Contraindications for spinal anesthesia puncture 10. Refuse to participate in this study or participate in other studies - |
Country | Name | City | State |
---|---|---|---|
China | Six Affiliated Hospital, Sun Yat-sen University | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Sixth Affiliated Hospital, Sun Yat-sen University |
China,
Ball L, Dameri M, Pelosi P. Modes of mechanical ventilation for the operating room. Best Pract Res Clin Anaesthesiol. 2015 Sep;29(3):285-99. doi: 10.1016/j.bpa.2015.08.003. Epub 2015 Sep 2. Review. — View Citation
Choi EM, Na S, Choi SH, An J, Rha KH, Oh YJ. Comparison of volume-controlled and pressure-controlled ventilation in steep Trendelenburg position for robot-assisted laparoscopic radical prostatectomy. J Clin Anesth. 2011 May;23(3):183-8. doi: 10.1016/j.jclinane.2010.08.006. Epub 2011 Mar 4. — View Citation
Dion JM, McKee C, Tobias JD, Sohner P, Herz D, Teich S, Rice J, Barry ND, Michalsky M. Ventilation during laparoscopic-assisted bariatric surgery: volume-controlled, pressure-controlled or volume-guaranteed pressure-regulated modes. Int J Clin Exp Med. 2014 Aug 15;7(8):2242-7. eCollection 2014. — View Citation
Kalmar AF, Foubert L, Hendrickx JF, Mottrie A, Absalom A, Mortier EP, Struys MM. Influence of steep Trendelenburg position and CO(2) pneumoperitoneum on cardiovascular, cerebrovascular, and respiratory homeostasis during robotic prostatectomy. Br J Anaesth. 2010 Apr;104(4):433-9. doi: 10.1093/bja/aeq018. Epub 2010 Feb 18. — View Citation
Mahmoud K, Ammar A, Kasemy Z. Comparison Between Pressure-Regulated Volume-Controlled and Volume-Controlled Ventilation on Oxygenation Parameters, Airway Pressures, and Immune Modulation During Thoracic Surgery. J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1760-1766. doi: 10.1053/j.jvca.2017.03.026. Epub 2017 Mar 22. — View Citation
Needham DM, Colantuoni E, Mendez-Tellez PA, Dinglas VD, Sevransky JE, Dennison Himmelfarb CR, Desai SV, Shanholtz C, Brower RG, Pronovost PJ. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ. 2012 Apr 5;344:e2124. doi: 10.1136/bmj.e2124. — View Citation
Respirator lung syndrome. Minn Med. 1967 Nov;50(11):1693-705. — View Citation
Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. Review. Erratum in: N Engl J Med. 2014 Apr 24;370(17):1668-9. — View Citation
Tran D, Rajwani K, Berlin DA. Pulmonary effects of aging. Curr Opin Anaesthesiol. 2018 Feb;31(1):19-23. doi: 10.1097/ACO.0000000000000546. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | occurrence rate of Oxygenation index=300mmHg | Oxygenation index(OI)=PaO2/FiO2 | 10minutes before anesthesia,1 hour after pneumoperitoneum,2 hour after pneumoperitoneum,30 minutes after after extubation | |
Secondary | Occurrence rate of pulmonary complications | Pulmonary complications were assessed using the Postoperation Pulmonary complication ( PPC) scale,The scale is divided into four grades, with 0 indicating no pulmonary complications and 1 to 4 indicating increasingly severe pulmonary complications. | Day 0 to 7 after surgery | |
Secondary | incidence of pneumonia | record the occurrence rate of pneumonia after surgery | Day 0 to 7 after surgery | |
Secondary | incidence of pulmonary atelectasis | record the occurrence rate of pulmonary atelectasis after surgery | Day 0 to 7 after surgery | |
Secondary | peak airway pressure | Peak airway Pressure(Ppeak, cm H2O) | through mechanical ventilation,average of 3 hours | |
Secondary | Plateau airway pressure | Plateau airway pressure(Pplat, cm H2O) | through mechanical ventilation,average of 3 hours | |
Secondary | Static lung compliance | Static lung compliance (Csta, ml/cm H2O) = Vt/ (Pplat-PEEP) | through mechanical ventilation,average of 3 hours | |
Secondary | Dynamic lung compliance | Dynamic lung compliance (Cdyn , ml/cm H2O)= Vt/ (Ppeak-PEEP) | through mechanical ventilation,average of 3 hours | |
Secondary | Arterial partial pressure of oxygen | Arterial partial pressure of oxygen (PaO2, mmHg) | 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation | |
Secondary | assessing change of Alveolar-arterial oxygen tension difference | Alveolar-arterial oxygen tension difference (mmHg) | 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation | |
Secondary | assessing change of Respiratory index | Fraction of inspired oxygen (FiO2); Respiratory index (RI) =Ratio of alveolar-arterial oxygen tension difference to FiO2 | 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation | |
Secondary | assessing change of Alveolar dead space fraction | Arterial carbon dioxide partial pressure (PaCO2); partial pressure of carbon dioxide in endexpiratory gas (PetCO2); Alveolar dead space fraction (Vd/Vt)=(PaCO2-PetCO2)/ PaCO2; | 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum,30 minutes after extubation | |
Secondary | assessing change of lactic acid | lactate ( LAC), mmol/L | 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation | |
Secondary | assessing change of Advanced glycation end products receptor | Advanced glycation end products receptor (RAGE, pg/ml) | 10 minutes before anesthesia,30 minutes after extubation | |
Secondary | assessing change of Tumor Necrosis Factor alpha | Tumor Necrosis Factor alpha (TNF-a, pg/ml) | 10 minutes before anesthesia,30 minutes after extubation | |
Secondary | assessing change of Interleukin 6 | Interleukin 6 (IL-6, pg/ml) | 10 minutes before anesthesia,30 minutes after extubation | |
Secondary | assessing change of Interleukin 8 | Interleukin 8 (IL-8, pg/ml) | 10 minutes before anesthesia,30 minutes after extubation | |
Secondary | assessing change of Clara cell protein 16, | Clara cell protein 16, | 10 minutes before anesthesia,30 minutes after extubation | |
Secondary | The occurrence rate of hypoxemia in PACU | The occurrence rate of hypoxemia (SPO2<90% or PaO2<60 mmHg) in PACU | 30 minutes after extubation | |
Secondary | Occurrence rate of operation complications | abdominal abscess, anastomotic fistula, bleeding and the incidence of reoperation within 7 days | within 7 days after operation | |
Secondary | Occurrence rate of Systemic complications | Systemic complications including sepsis and septic shock | within 7 days after surgery | |
Secondary | Antibiotic dosages | record the Antibiotic dosages within 7 days after surgery | within 7 days after surgery | |
Secondary | incidence of Unplanned admission to ICU | Unplanned admission to ICU within 30 days after surgery | within 30 days after surgery | |
Secondary | Length of ICU stay within 30 days after surgery | Length of ICU stay within 30 days after surgery | within 30 days after surgery | |
Secondary | Length of hospital stay within 30 days after surgery | Length of hospital stay within 30 days after surgery | within 30 days after surgery | |
Secondary | Death from any cause | Death from any cause 30 days after surgery | within 30 days after surgery | |
Secondary | The occurrence rate of hypoxemia after surgery | The occurrence rate of hypoxemia (SPO2<90% or PaO2<60 mmHg) after surgery | within 7 days after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05054270 -
Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
|
||
Not yet recruiting |
NCT04470297 -
Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19
|
Phase 2 | |
Not yet recruiting |
NCT01184313 -
Acute Lung Injury After Aortic Valve Surgery
|
N/A | |
Not yet recruiting |
NCT06446544 -
Functional Residual Capacity and Alveolar Recruitment in Single-lung Ventilation: a Randomized Study
|
N/A | |
Not yet recruiting |
NCT06296173 -
Open Lung Protective Extubation Following General Anesthesia
|
N/A | |
Not yet recruiting |
NCT03661502 -
Effect of Variable Volume Ventilation on Lung Compliance
|
N/A | |
Recruiting |
NCT04296071 -
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
|
||
Completed |
NCT04645316 -
The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung
|
N/A | |
Recruiting |
NCT02299921 -
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
|
||
Recruiting |
NCT05559970 -
Inhalational Sedation and Mechanical Power
|
N/A | |
Completed |
NCT03581006 -
Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
|
||
Recruiting |
NCT05228717 -
Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
|
||
Recruiting |
NCT04372953 -
Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial).
|
N/A | |
Not yet recruiting |
NCT05363085 -
The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)
|
||
Recruiting |
NCT02444858 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury
|
Phase 1/Phase 2 | |
Completed |
NCT03924206 -
Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
|
||
Recruiting |
NCT06416709 -
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01939067 -
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
|
Phase 1 | |
Recruiting |
NCT05401474 -
Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW)
|
N/A | |
Completed |
NCT03437499 -
Adrenomedullin Changes After Sustained Inflation or Positive Pressure Ventilation at Birth
|
N/A |